Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxis Health has demonstrated the feasibility of using wearable biometric sensors combined with machine learning algorithms to predict episodes of emotional dysregulation among young children, particularly those with ADHD. Their recent observational study showed that continuous physiological data can be used to identify early warning signs before behavioral outbursts occur, enabling timely interventions by caregivers or educators. The approach aims to provide real-time support through their Family Coping Coach platform, empowering families to manage children's mental health proactively.[1][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxis Health.